In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Competitive Edge Super Sharp in Hopeful Romp
- Miss Serendipity, Blanc Snatch Yellow Ribbon
- Del Mar Trainers to Hop in Bouncey Ball Race
- Sharp Sensation Edges Ben's Cat in 'Monster
- Cary Street Rides Rail to Greenwood Surprise
- Protonico Surges in Smarty Jones for Pletcher
- Ring Weekend at Home on Turf in Saranac Win
- Fall Meet at Los Alamitos Begins Sept. 5
- Belmont Fall Championship Meet Opens Sept. 5
- Breeder, Businessman Garvin Dies at Age 71